Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes.
Saved in:
| Title: | Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes. |
|---|---|
| Authors: | Agarwal R; Division of Nephrology, Richard L. Roudebush VA Medical Center, Indianapolis.; Indiana University School of Medicine, Indianapolis., Green JB; Division of Endocrinology, Department of Medicine and Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC., Heerspink HJL; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Mann JFE; KfH (Kuratorium für Dialyse und Nierentransplantation) Kidney Center, Munich, Germany.; Department of Nephrology and Hypertension, Friedrich Alexander University, Erlangen, Germany., McGill JB; Division of Endocrinology, Metabolism and Lipid Research, Washington University in St. Louis, School of Medicine, St. Louis., Mottl AK; University of North Carolina (UNC) Kidney Center, UNC School of Medicine, Chapel Hill., Rosenstock J; Velocity Clinical Research at Medical City, Dallas., Rossing P; Steno Diabetes Center Copenhagen, Copenhagen.; Department of Clinical Medicine, University of Copenhagen, Copenhagen., Vaduganathan M; Division of Cardiovascular Medicine, Brigham and Women's Hospital-Harvard Medical School, Boston., Brinker M; Cardiology and Nephrology Clinical Development, Bayer, Wuppertal, Germany., Edfors R; Department of Clinical Sciences, Danderyd University Hospital, Division of Cardiovascular Medicine, Karolinska Institutet, Stockholm., Li N; Bayer Healthcare, Chaoyang District, Beijing., Scheerer MF; Global Medical Affairs and Pharmacovigilance, Bayer, Berlin., Scott C; Clinical Statistics and Analytics, Bayer, Whippany, NJ., Nangaku M; Division of Nephrology and Endocrinology, University of Tokyo Graduate School of Medicine, Tokyo. |
| Corporate Authors: | CONFIDENCE Investigators |
| Source: | The New England journal of medicine [N Engl J Med] 2025 Aug 07; Vol. 393 (6), pp. 533-543. Date of Electronic Publication: 2025 Jun 05. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial |
| Journal Info: | Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
